PharmiWeb Today Story
Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce the latest life-changing medicines
INDIANAPOLIS and LINCOLNSHIRE, Ill., April 22, 2024 – Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.
The acquisition of this FDA-approved facility in Pleasant Prairie, Wisconsin will further expand Lilly's global parenteral (injectable) product manufacturing network and support increased demand for the company's medicines. Lilly estimates that production at this facility could begin at the end of 2025.
“The acquisition of this state-of-the-art facility underscores our unwavering commitment to growth and innovation, and we look forward to welcoming talented new Nexus colleagues to Lilly from the Pleasant Prairie facility,” said Edgardo Hernandez, executive vice president and president, Lilly manufacturing. “We are investing boldly to serve our patients, to meet product demand and to build capabilities for our robust pipeline of the future.”
Usman Ahmed, president and chief executive officer of Nexus, added: “We are excited Lilly is continuing our family’s mission of providing lifesaving medications to those who need them most. This milestone is a testament to the dedication of our Nexus employees in building a best-in-class injectable manufacturing facility. The combination of our teams and infrastructure with Lilly’s global platform will benefit…
Read More...Articles
What Does a Clinical SAS Programmer Do?
16-Apr-2024
The Evolution of Clinical Data Management
10-Apr-2024
9 Clinical Data Management Career Paths
08-Apr-2024
Featured Events
-
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
UK Clinical Research: A Professional Awareness Upd…
26-Jan-2022 - 27-Jan-2022 -
Pharma USA 2022
16-Mar-2022 - 17-Mar-2022 -
PM Society: Measuring Patient Engagement: Opening…
12-Oct-2022 - 12-Oct-2022 -
Finding the Value in Strategic Outsourcing Partner…
22-Feb-2023 - 22-Feb-2023 -
Reuters Events: Pharma USA 2023
28-Mar-2023 - 29-Mar-2023
News
-
Petros Pharmaceuticals Expands Online Distribution…
23-Apr-2024 -
Nature’s Answer Introduces Maca Root Extract to It…
23-Apr-2024 -
Nava Health Expands Columbia Location to Meet Grow…
23-Apr-2024 -
CNS Pharmaceuticals to Present at the LSX World Co…
23-Apr-2024 -
SpendMend Achieves HITRUST Implemented, 1-Year (I1…
23-Apr-2024 -
Lash ME NYC Promotes New Exhaustive Range of Lash…
23-Apr-2024